Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00134953
Status:
TERMINATED
Last Update Posted:
2007-12-17
First Post:
2005-08-23
Brief Title:
Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment
Sponsor:
Novartis
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-01
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2004-05
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-23
First Submit QC Date:
August 23 2005
Study First Post Date:
2005-08-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2007-12-14
Last Update Post Date:
2007-12-17
Last Update Post Date Type:
ESTIMATED